Most importantly, Kaplan–Meyer survival and Cox regression analyses based on the expression level of MKRN3 strengthened the notion that MKRN3 represents a valuable prognosis biomarker with predictive potential in patients with SCCHN. The gene discussed is MKRN3; the disease is head and neck squamous cell carcinoma.